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ABSTRACT
Many diseases are potential targets for gene therapy using either non-viral or viral vectors.  Unlike non-
viral methods, viral vectors, such as lentiviruses, have the ability to integrate into the host chromosome, 
which can lead to long-term transgene expression.  Lentiviruses have advantages over other types of 
viruses due to their capacity to transduce non-dividing cells.  An optimized generation of lentiviruses 
carrying green fluorescent protein (GFP) reporter gene driven by either UbC (LV/UbC/GFP) or 
CMV (LV/CMV/GFP) promoter is described in this paper.  The lentiviruses were produced by co-
transfecting lentiviral expression constructs and packaging mix into 293FT lentivirus producer cell lines. 
Lipofectamine was highly efficient in transfecting the cells compared to Transfast and Polyethyleneimine 
(PEI).  Following cell transfection, syncytia were clearly visible at day 2.  Lentiviruses were harvested 
at days 1, 2 and 3 post-transfection.  The highest transduction efficiency was read from LV/CMV/GFP 
harvested at day 2 post-transfection and LV/UbC/GFP harvested at day 3 post-transfection.  Finally, 
the GFP expression in COS-7 cells was determined at day 2 and day 14 post-transduction for transient 
and stable GFP expression.  It was found that the GFP expression declined overtime.  However, the 
transduction efficiency and duration of the transgene expression in COS-7 cells transduced with LV/CMV/
GFP were higher compared to LV/UbC/GFP.  In conclusion, we have successfully produced lentiviruses 
carrying GFP with different promoters and shown that the viruses were able to infect COS-7 cells at 
different efficiencies.  Meanwhile, the generation of the active lentiviruses will allow us to proceed to 
Article history:
Received: 6 December 2010
Accepted: 18 April 2011
Email addresses: 
eunice_ngai@yahoo.com (Siew Ching Ngai), 
r.rajesh@medic.upm.edu.my (Rajesh Ramasamy), 
syahril@medic.upm.edu.my (Syahril Abdullah)
*Corresponding Author
aPresent address:
Division of Human Biology, International Medical University, 
57000 Kuala Lumpur, Malaysia
Siew Ching Ngai, Rajesh Ramasamy and Syahril Abdullah
270 Pertanika J. Sci. & Technol. 20 (2): 269 - 281 (2012)
INTRODUCTION
Gene therapy is the introduction of a therapeutic gene into target cells to replace, manipulate 
or supplement non-functional or misfunctioning genes to treat diseases (Yang et al., 2006). 
Unlike non-viral methods, which are limited by their low rate of gene transfer and short duration 
of transgene expression, retroviral vectors have the ability to integrate into the host genome 
permanently, and this can further lead to a long-term transgene expression (Malik & Arumugam, 
2005).  Recombinant retroviruses derived from murine leukemia viruses are widely used as 
a gene transfer vector in research and clinical settings (Verma & Somia, 1997).  However, 
retroviral vectors can only transduce actively dividing cell (Lewis & Emerman, 1994), and 
thus limit their application in gene therapy.
Lentiviruses are a genus of slow viruses of Retroviridae family, many of which, produce 
tumours (Kontaratos et al., 2010).  They resemble retroviruses in their ability to integrate 
the transgene into the cell genome, which is in theory, should lead to a permanent transgene 
expression.  Hence, lentivirus vectors have appeared to be an attractive gene therapy vector due 
to their ability to transduce non-proliferating cells (Bukrinsky et al., 1993; Gallay et al., 1997; 
Gallay et al., 1995).  In 2010, lentiviruses have been applied in about 1.8% of the gene therapy 
clinical trials for various diseases (http://www.wiley.co.uk/genmed/clinical/[June2010]). 
Although lentiviruses are created based on human immunodeficiency virus type (HIV)-1, the 
lentiviruses used for the purpose of gene therapy have been modified to enhance their biosafety 
features (Dull et al., 1998).  In the first generation of HIV-derived vectors (Naldini et al., 1996), 
the hybrid viral particles were produced from the expression of HIV-1 core proteins, enzymes, 
accessory factors and envelope of vesicular stomatitis virus G glycoprotein (VSVG) (Burns et 
al., 1993).  In the second version, the component plasmids of the lentivirus have been reduced 
to gag, pol, tat and rev genes (Zufferey et al., 1997).  In the latest generation of the lentivirus 
system (the third-generation), only a fractional set of HIV genes were used (gag, pol and rev). 
A deletion in the 3’LTR of the lentiviral expression construct resulted in a “self-inactivation” 
of the lentivirus after transduction into the target cells (Zufferey et al., 1998), rendering the 
proviral components to be unable to produce more viruses.  The lentivirus was generated by 
the co-transfection of lentiviral expression plasmid with three lentiviral component plasmids 
in the transformed embryonal human kidney cells (293FT).  These component plasmids supply 
the structural and replication proteins in trans for the generation of a complete virion.  The co-
transfection process can be performed by using a myriad of transfection agents, such as FuGene, 
GeneJuice, Lipofectamine, Transfast, Polyethyleneimine and several others.  Meanwhile, the 
lentivirus can be harvested a day or few days post-transfection.
The transduction efficiency of the lentivirus vectors is regulated by many regulatory 
elements, such as promoters, enhancers, polyadenylation signals, etc.  Lentiviral vectors can 
be designed to carry different types of promoters, depending on the target cell type and the 
target gene.  The commonly used human cytomegalovirus (CMV) immediate-early promoter/
enhancer has been shown to generate efficient and high level of gene expression (Andersson 
et al., 1989; Boshart et al., 1985; Nelson et al., 1987).  Meanwhile, increased transduction 
efficiency and transgene expression were observed with CMV promoter in the presence of 
central polypurine tract (cPPT) and woodchuck posttranscriptional regulatory element (WPRE) 
in a lentiviral gene delivery context (Barry et al., 2001).  Interestingly, it has been reported 
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that human ubiquitin C (UbC) promoter generates a higher expression level of transgene in 
a wider range of tissues as compared to other routinely used promoters, such as H2-K, CMV 
or Pgk-1 (Schorpp et al., 1996).  In a non-viral context, Gill et al. (2001) reported that UbC 
promoter directs higher and more durable transgene expression as compared to the CMV 
promoter in the lung of mouse.
In the present study, two types of lentivirus vectors carrying green fluorescent protein 
(GFP) reporter gene were produced.  One was driven by UbC promoter (LV/UbC/GFP) and 
the other by CMV promoter (LV/CMV/GFP).  Unlike LV/UbC/GFP, LV/CMV/GFP contained 
cPPT and WPRE.  Prior to the production of lentivirus, different types of transfection reagents 
were tested for their transfection efficiency in order to select the most effective transfection 
reagent.  Lentiviruses were harvested at different days of post-transduction to determine the 
highest titre of the lentivirus produced.  Finally, the transduction efficiency of LV/UbC/GFP 
and LV/CMV/GFP in African green monkey kidney fibroblast (COS-7) were also checked for 
the transient and stable GFP expression.
MATERIALS AND METHODS
Cell Cultures
Transformed embryonal human kidney (293FT) and African green monkey kidney fibroblast 
(COS-7) cell lines were purchased from Invitrogen (Carlsbad, CA, USA) and American Type 
Culture Collection (ATCC) (Manassas, VA, USA), respectively.  The 293FT cells were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich, MO, USA) supplemented 
with 6 mM L-glutamine (PAA Laboratories GmbH, Austria), 0.1 mM MEM non-essential amino 
acids (PAA Laboratories GmbH), 1 mM MEM sodium pyruvate (Sigma-Aldrich), 50 μg/ml 
Geneticin (Gibco BRL, Paisley, UK) and 10% foetal bovine serum (FBS) (Gibco).  COS-7 
cells were cultured in DMEM supplemented with 10% FBS.  The cells were maintained at 
37°C in humidified 5% CO2 atmosphere.
Construction of the Lentiviral Expression Vectors
Plasmid phMGFP (Promega, Madison, WI, USA) was transformed into E. coli JM109 
Competent Cells (Promega), whereas the pENTRTM4 (Invitrogen) was transformed into Library 
Efficiency® E. Coli DB3.1TM Competent Cells (Invitrogen).  The plasmids were purified using 
PureLinkTM HQ Mini Plasmid Purification kit  (Invitrogen).  The plasmids were restriction 
digested and subjected to agarose gel electrophoresis to separate the GFP and pENTRTM 
backbone from the other digested fragments.  Following gel extraction, the GFP was subcloned 
into the pENTRTM4.  The resulting pENTRTM4/GFP was verified using a restriction enzyme 
analysis on agarose gel.  Next, a recombination reaction was performed between pENTRTM4/
GFP and pLenti6/UbC/V5-DEST (Lentivirus plasmid destination vector construct) (Invitrogen) 
using LR ClonaseTM II enzyme mix (Invitrogen) to produce pLenti6/UbC/GFP/V5-DEST.  The 
product was transformed into One Shot® Stbl3TM chemically competent E. coli (Invitrogen) and 
verified using the restriction enzyme analysis and DNA sequencing.  Meanwhile, pLenti6/CMV/
GFP/V5-DEST plasmid was purchased from Invitrogen and used as a control in this study.
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Transfection
293FT cells were seeded in 24-well tissue culture plate at 5 x 104 cells per well.  After 24 hours 
of culturing, the cells were transfected with 1 mg of phMGFP, pLenti6/UbC/GFP/V5-DEST 
(pL/UbC/GFP) or pLenti6/CMV/GFP/V5-DEST (pL/CMV/GFP) by using Lipofectamine 
(Invitrogen), Polyethyleneimine (PEI) (Sigma-Aldrich) or Transfast (Promega), according to 
the protocol suggested by the manufacturer.  The medium containing the transfection mixture 
was discarded and replaced with fresh DMEM complete medium at day 1 post-transfection. 
The transfection efficiency was evaluated as a percentage of GFP-expressing cells within the 
total cells acquired by flow cytometry analysis at day 2 post-transfection.
Lentivirus Production
Lentivirus vectors, pseudotyped with vesicular stomatitis virus G glycoprotein (VSV-G), were 
generated.  Briefly, 293FT cells (1 x 106 cells per well in 6-wells tissue culture plate) were 
co-transfected with packaging mix (plasmids to provide structural and replication proteins in 
trans required to produce the virions) (Invitrogen)  and the lentiviral expression plasmid (pL/
UbC/GFP or pL/CMV/GFP) in the OptiMEM (Invitrogen) medium.  The packaging mix is 
comprised of three expression plasmids encoding the packaging protein gag-pol (pLP1), rev-
expressing construct (pLP2) and VSVG-expressing construct (pLP/VSV-G).  Meanwhile, the 
morphology of the cells was analyzed under inverted brightfield microscopy examination for 
the presence of syncytia, and virus supernatant was harvested after 24, 48 and 72 hours by 
centrifugation at 1000 x g for 15 minutes at 4°C.  The lentiviruses produced were LV/UbC/
GFP (GFP expression controlled by UbC promoter) and LV/CMV/GFP (GFP expression 
controlled by CMV promoter).
Transduction Efficiency
COS-7 cells were seeded at 5 x 104 cells per well in 24-well tissue culture plates .  On the 
following day, the cells were transduced with LV/UbC/GFP or LV/CMV/GFP in a complete 
DMEM tissue culture medium with polybrene (Sigma) at a final concentration of 6 mg/ml.  The 
medium containing the virus was removed and replaced with fresh complete medium at day 
1 post-transduction.  At day 2 post-transduction, growth medium was removed and replaced 
with a dissociation solution.  The GFP expression of COS-7 transduced with the viruses was 
evaluated as a percentage of GFP-expressing cells within the total cells acquired by flow 
cytometry.  The percentage of the GFP expression was used to calculate the titre of lentivirus. 
Once the titre of the viruses had been determined, the GFP expression was evaluated at day 
2 and 14 post-transduction for the transient and stable expression at multiplicity of infection 
(MOI) of 0.8.
Flow Cytometry
The cells were dissociated and centrifuged at 250 x g for 5 minutes to remove residual media 
components.  Next, the cell pellet was resuspended in PBS with 1% foetal bovine serum. 
The total events of 10,000 were  set.  The cells were analyzed for green fluorescence by 
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FACSvantage (Becton Dickinson, San Jose, CA) using CellQuest software.  Dead cells were 
excluded and negative green fluorescence was set at around 1% for the untreated cells.
Statistical Analysis
Numerical data were expressed as mean with standard deviations.  ANOVA was applied to 
compare the means of the experiment samples, followed by a post-hoc test to determine the 
statistical significance in the mean difference.  The differences with P ≤ 0.05 were considered 
to be statistically significant.
RESULTS AND DISCUSSION
Construction of Lentiviral Expression Vector
Successful gene delivery into somatic cells relies on the ability of the gene delivery vector to 
deliver the gene with high efficiency.  Lentivirus (LV) was selected for this study because it 
can transduce non-proliferating cell (Zufferey et al., 1997) and integrate into the host genome 
(He et al., 2005).  In addition, Dull et al. (1998) reported that the LV was highly efficient for 
in vivo gene delivery and exhibited prolonged transgene expression in several tissues.  In this 
study, the production of two types of LV vectors carrying GFP reporter gene, driven by a UbC 
(LV/UbC/GFP) or CMV (LV/CMV/GFP) promoter, are described.  Unlike LV/UbC/GFP, LV/
CMV/GFP contains two additional cis-acting regulatory sequences, namely, the Woodchuck 
Post-transcriptional Regulatory Element (WPRE) and the central Polypurine Track (cPPT).  
To construct the lentiviral expression vector carrying GFP reporter gene, driven by UbC 
promoter, a GFP gene from phMGFP was subcloned into a pENTR4 to generate pENTR4/
GFP, which is an entry clone for the Gateway Expression System.  Subsequently, the LR 
recombination reaction was performed between pENTR4/GFP and pLenti6/UbC/V5-DEST 
to generate pLenti/UbC/GFP/V5-DEST (pL/UbC/GFP).  The resulting construct was verified 
by restriction enzyme analysis and sequencing.  The lentiviral expression vector construct 
pLenti/CMV/GFP/V5-DEST (pL/CMV/GFP), which is driven by CMV promoter with extra 
Fig.1: Genomic structure of the lentiviral expression vectors; (a) The LV construct encoding GFP under 
the control of the UbC promoter, (b) The LV construct encoding GFP under the control of the CMV 
promoter with cPPT and WPRE.  Long terminal repeat (LTR), HIV-1 psi packaging signal (ѱ), HIV-1 
Rev-response element (RRE), Polypurine Tract from HIV (cPPT), human ubiquitin C promoter (PUbC), 
human cytomegalovirus immediate-early promoter (PCMV), Green Fluorescent Protein reporter gene 
(GFP), Woodchuck Posttranscriptional Regulatory Element (WPRE) are indicated
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post-transcriptional regulatory element (WPRE) and transduction enhancer (cPPT), was used 
as a control.  The genomic structure of the lentiviral expression vectors is shown in Figure 1.
Transfection Efficiency of Lipofectamine, Polyethyleneimine (PEI) and Transfast on 
293FT
To produce the virus, the 293FT cells were co-transfected with lentiviral expression vector and 
the packaging mix.  Due to the myriad of the transfection agents available, it was pertinent to 
select the transfection agent that could shuttle the plasmids into the cells efficiently.  In this 
study, the transfection efficiency of Lipofectamine, Transfast and Polyethyleneimine (PEI) was 
compared.  Plasmids pL/UbC/GFP and pL/CMV/GFP were transfected into 293FT cell lines 
and the cells were subjected for examination under fluorescent microscopy and flow cytometry 
at day 2 of post-transfection.
GFP expression was observed from the cells transfected with pDNAs by all the transfection 
agents tested (see Fig. 2).  Transfast and Lipofectamine appeared to be more efficient at 
transfecting cells compared to PEI, based on the number of the cells transfected qualitatively. 
With Transfast, the transfected cells were evenly spread across the plate, whereas the 
transfection by Lipofectamine was localized to a few populations of the cells.  Meanwhile, the 
delivery of the naked pDNAs did not show qualitatively significant GFP expression.
The flow cytometry analysis was performed to further verify the qualitative observations. 
The percentage of 293FT cells transfected with the pDNAs using Lipofectamine and Transfast 
was found to be significantly higher than PEI and naked pDNA (Figure 3).  For Lipofectamine, 
the percentages of the cells with GFP reading were 72.15, 81.90 and 92.29 for pL/UbC/
GFP, pL/CMV/GFP and phMGFP, respectively.  Transfast showed GFP readings of 71.00% 
(pL/UbC/GFP), 86.72% (pL/CMV/GFP) and 67.60% (phMGFP).  Although Lipofectamine 
showed a trend of higher percentage of a number of cells transfected, the values were not 
significantly different than Transfast.  The transfection efficiency of PEI was the lowest among 
the transfection reagents, with GFP readings of 9.93% (pL/UbC/GFP), 13.92% (pL/CMV/GFP) 
and 4.30% (phMGFP). Mock transfections without transfection agent showed values that are 
less than 2% for all the pDNAs.
To produce the virus, the lentiviral expression plasmid construct was co-transfected with 3 
other plasmids (pLP1, pLP2 and pLP/VSV-G) in packaging mix, which provide the structural, 
replication protein and envelope of the virus in trans.  Prior to the production of the virus, 
different transfection reagents were tested for their ability to transfect the GFP expression 
plasmids (pL/UbC/GFP, pL/CMV/GFP and phMGFP) into the 293FT LV producer cell line 
efficiently.  Among the transfection reagents tested, Lipofectamine exhibited the highest 
transfection efficiency.  Therefore, Lipofectamine was used to co-transfect the packaging 
mix and the GFP expressing LV plasmid (either pL/UbC/GFP or pL/CMV/GFP) into the LV 
producer cell line to produce the virus.
Lentivirus Production and Infectivity
Lentivirus was generated by the co-transfection of 293FT cells with packaging mix (pLP1, 
pLP2 and pLP/VSV-G) and a lentiviral expression plasmid construct (either pL/UbC/GFP or 
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pL/CMV/GFP), using Lipofectamine as the transfection reagent.  As shown in Fig. 4, syncytia 
were clearly visible at day 2 post-transfection.  The formation of syncytia is a sign for the 
lentivirus production.  Meanwhile, the formation of the multinucleated cells implied that the 
packaging plasmid had been transfected and expressed successfully in the 293FT cells.  The 
formation of syncytia was due to the expression of VSV-G glycoprotein translated from pL/
VSVG, which subsequently caused the fusion of the 293FT cells into large and multinucleated 
cells.  Lentiviruses LV/UbC/GFP and LV/CMV/GFP were harvested at days 1, 2 and 3 post-
transfection.  To determine the infectivity of the virus, COS-7 cells were transduced with the 
Fig.2: Fluorescent microscopy of the GFP expression in the 293FT cell lines transfected with different 
plasmids using different transfection reagents;  Original magnification x20
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harvested viruses and the percentage of GFP expressions was determined by flow cytometry 
at day 2 of post-transduction.
Based on the information illustrated in Fig. 5, LV/UbC/GFP harvested at day 3 post-
transfection showed the highest GFP expression (32.81%) although the reading was not 
statistically different from the virus harvested at day 2 (19.74%).  For LV/CMV/GFP, the 
lentivirus harvested at day 2 post-transfection showed the highest GFP reading, followed by 
day 3 and day 1 post-transfection, with GFP expressions of 89.41%, 83.48% and 46.86%. 
In general, the results also exhibit that the GFP readings from LV/CMV/GFP at all days of 
post-transfection were significantly higher compared to LV/UbC/GFP.  Since there were no 
significant differences between the values of both the viruses harvested at day 2 and day 3, it 
was decided that the lentiviruses should be harvested at day 2 post-transfection for the following 
experiments to avoid the risks of contamination.
Fig.3: Transfection efficiency using Transfast, Lipofectamine and PEI in the 293FT cell line with plasmid 
pL/UbC/GFP, pL/CMV/GFP and phMGFP.  The GFP expression was measured at 48h post-transfection 
as the percentage of GFP-expressing cells within the total cells acquired.  Data are presented as mean ± 
SD of experiments conducted in triplicates
Fig.4: The morphology of the 293FT cell line transfected with lentiviral vector expression plasmid and 
packaging mix at day 2 of post-transfection; (A) Untreated cells, (B) Transfected cells.  293FT cells were 
fused together and became multinucleated (syncytia). (C) A single multinucleated cell from the original 
photo. 293FT cells were examined under inverted brightfield microscope at original magnification x20
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The harvested lentivirus was subsequently used to transduce COS-7 cells.  Higher 
transduction efficiency was obtained from the cells transduced with LV/CMV/GFP compared 
to LV/UbC/GFP harvested at all days post-transfection even though the same parameters had 
been used to produce both the viruses.  It was speculated that the higher GFP expression by LV/
CMV/GFP was either caused by the differences in the promoter used or by the incorporation of 
WPRE and cPPT in LV/CMV/GFP.  A previous study reported that the incorporation of WPRE 
and cPPT into lentiviral vector driven by CMV promoter provided increased transduction 
Fig.5: The GFP expression of COS-7 cells transduced with either LV/UbC/GFP or LV/
CMV/GFP harvested at days 1, 2 and 3 post-transfection.  The GFP expression was 
measured at day 2 post-transduction as the percentage of the GFP-expressing cells 
within the total cells acquired.  Data are presented as the mean ± SD of experiments 
conducted in triplicates
Fig.6: The GFP expression of COS-7 cell lines transduced either with LV/UbC/GFP 
or LV/CMV/GFP at MOI of 0.8.  GFP was measured as the percentage of the GFP-
expressing cells within the total cells acquiredat day 2 and day 14 post-transduction.  
Data are presented as the mean ± SD of the experiments conducted in triplicates
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efficiency (Barry et al., 2001).  However, Gill et al. (2001) reported that UbC promoter 
generated greater transgene expression as compared to CMV promoter in a non-viral gene 
delivery context.  The main reason for the high transgene expression by the LV/CMV/GFP 
will only be determined when a new LV/UbC/GFP is developed with the presence of WPRE 
and cPPT in future investigations.
Transient and Stable Lentivirus Reporter Gene Expression
GFP activities were also evaluated for the transient and stable expression.  Prior to this 
experiment, the Multiplicity of Infection (MOI) of 0.8 was detected as the most efficient 
MOI for COS-7 cells transduction (data not shown).  Therefore in this study, the cells were 
transduced with LV/UbC/GFP and LV/CMV/GFP at MOI of 0.8 in the presence of Polybrene. 
The medium was replaced at day 1 post-transduction and the cells were subjected to flow 
cytometry analysis at day 2 and day 14 post-transduction.  As illustrated in Fig. 6, the GFP 
expressions for COS-7 transduced with LV/UbC/GFP (33.92%) and LV/CMV/GFP (68.5%) 
were significantly higher at day 2 post-transduction as compared to day 14 post-transduction 
(LV/UbC/GFP of 3.1% and LV/CMV/GFP of 8.82%).  The results also show that the GFP 
expression of the cells transduced with LV/CMV/GFP was approximately 2-folds higher than 
the cells transduced with LV/UbC/GFP at both time points of the study.
The reduction in GFP expression from the cells transduced by both viruses diminished 
over time, which might be due to transgene silencing or promoter attenuation.  Nevertheless, 
the GFP readings for both LV/CMV/GFP and LV/UbC/GFP at day 14 post-transduction were 
still significantly high as compared to the untreated control.  Similar results were also seen 
with the GFP expression from murine embryonic carcinoma (EC) P19 cells transduced with the 
LV (He et al., 2005).  The authors reported that the decrease in the transgene expression was 
due to the transcriptional silencing and not by the deletion of the transgene.  Meanwhile, DNA 
methylation and chromatin modification have been reported as the two modes of epigenetic 
control of genome function (Ou et al., 2007).  These may lead to the GFP silencing as observed 
in our study.  Based on the results obtained in the current study, the cells transduced by LV/
UbC/GFP were probably subjected to the transgene silencing more severely as compared to 
the cells that were transduced by LV/CMV/GFP.  Hence, it was speculated that the transgene 
silencing was caused by the DNA methylation at the CpGs site in the promoter region.  The 
UbC promoter has more CpGs (88 CpGs) as compared to CMV promoter (30 CpGs), and 
therefore, it may be prone to the silencing effects compared to the CMV promoter.  To further 
confirm whether methylation at the CpG site was the factor for the transgene silencing, sodium 
bisulfate sequencing performed to compare the percentage of methylation in the UbC and CMV 
regions in the upcoming study.
The reporter gene, driven by UbC promoter, has been reported to exhibit higher transgene 
expression in vivo as compared to its CMV counterpart, in a non-viral gene delivery context 
(Gill et al., 2001).  However, in the LV gene delivery context study, the LV/CMV/GFP has 
been shown to exhibit better transduction efficiency and a stable gene expression as compared 
to LV/UbC/GFP.  The superior results exhibited by the LV/CMV/GFP in this study could be 
due to the presence of cPPT and WPRE in the viral construct.  In addition, the LV vector, with 
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cPPT in its construct, has been shown to have high copy number of provirus integrated into 
the host genome (Park & Kay, 2001), and thus resulting in the higher reporter gene expression. 
Sirven et al. (2000) also reported that the inefficiency of gene transfer by lentivirus, which was 
due to the limitation of nuclear translocation, had been overcome by the presence of cPPT. 
Meanwhile, WPRE, which is purified from woodchuck hepatitis virus, has been exploited 
as an enhancer of the transgene expression by increasing the nuclear export of mRNA to the 
cytoplasm and subsequently increased protein synthesis (Mastroyiannopoulos et al., 2005).
CONCLUSION
The production of two types of lentiviral vectors has been described in the current study.  As 
indicated earlier, the two types of lentiviral vectors are driven differently; one driven by a 
UbC promoter (LV/UbC/GFP) and the other by CMV promoter with two additional cis-acting 
regulatory sequences (LV/CMV/GFP).  Among the transfection reagents tested to deliver the 
lentiviral construct and structural plasmids into the 293FT cells, Lipofectamine showed the 
highest transfection efficiency.  The higher transduction efficiency and gene expression were 
exhibited by LV/CMV/GFP as compared to LV/UbC/GFP.  The successful production of these 
lentiviruses will allow the researchers to further analyze the effects of the UbC promoter and 
the two regulatory sequences in the LV construct in the subsequent study.
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